Sean C. Flynn

Vericel CLO Sean Flynn sells 15,000 shares ($603.2K) on scheduled 10b5-1 plan; retains 1,647 shares plus 70,000 stock options.

Sean C. Flynn, Chief Legal Officer of Vericel Corp, sold 15,000 shares at $40.21 under a pre-arranged 10b5-1 trading plan adopted on 2025-12-02. Post-sale, he retains 1,647 non-derivative shares and 70,000 stock options, so his overall position remains intact. The sale is scheduled, not discretionary, limiting inference about executive sentiment. Vericel shows mixed fundamentals: strong annual revenue growth of +16.4% but recent quarterly net income of $-6.3M and an elevated P/E of 96.36, suggesting the market is pricing in future profitability improvements. Flynn's prior sales at VCEL show mixed timing outcomes (90-day returns ranging from -19.3% to +14.3%), with no clear pattern of prescience; his cross-ticker track record average of -3.0% over 90 days post-sale is similarly uninformative on this specific stock.

CLO Flynn sells 21,421 shares at blended $35.18; reduces holdings to 1,262 shares (-94.4%)

Sean C. Flynn, Chief Legal Officer of Vericel Corp, executed 2 separate sales on 2026-03-02 totaling 21,421 shares for $753,529.75 (blended average price $35.18), reducing his post-transaction holdings to 1,262 shares from a pre-transaction position of 22,683 shares. This represents a -94.4% reduction in his stake. At the current price of $34.96, the stock is -32.2% from its 52-week high of $51.53, and has declined -5.4% in the past 30 days. Flynn's prior 4 sales at VCEL have shown a mixed timing record: 3 were poorly timed (90d returns of +1.6%, +6.7%, +2.9%) while 1 was well-timed (-19.3% after the 2024-07-16 sale). Across his broader cross-ticker track record, 4 prior sells averaged a 90-day return of -2.0% with a 25.00% well-timed rate, but his VCEL-specific history shows 1 of 4 prior sales were well-timed at the 90-day mark. The magnitude of this near-total liquidation—removing 94.4% of holdings in a single filing—stands out relative to his prior transaction sizes at this ticker and warrants attention to whether operational or personal circumstances are driving this reshuffling.

CFO Flynn sells 15,000 VCEL shares (95.5% of holdings) at $52.18; stock -3.2% from 52-week high, -$782.7K transaction

Flynn Sean C., Chief Legal Officer, divested 15,000 shares at $52.18, reducing his holdings by 95.5% to just 707 shares. The sale occurred near the 52-week high ($52.90) with the stock at +18.1% over 30 days and +17.1% over 90 days, suggesting a sale in a period of strong price appreciation. Prior same-ticker history shows Flynn executed three consecutive sales on June 20–24, 2024, now followed by this July 16 sale—a pattern of repeated dispositions concentrated within weeks. Vericel's fundamentals show the company is unprofitable (full-year net income was negative) despite +20.2% revenue growth, presenting a misaligned signal between operational performance and stock price momentum. The near-complete exit of the CLO's position, sustained across multiple tranches in a compressed timeframe during elevated valuations, merits attention to whether cash generation or market conditions are driving the disposition sequence.

Chief Legal Officer Sean C. Flynn sold 15,000 shares (96.9% of holdings) at $45.11 average; post-sale holds only 487 shares.

Flynn executed 3 separate sales totaling 15,000 shares for $676,643.76 over three trading days (June 20-24, 2024) at prices between $45.02 and $45.84, reducing his stake from 15,487 shares to 487 shares. This represents a near-complete liquidation of his position at a time when the stock trades at $46.19 current price, -4.2% over 30 days and -6.8% over 90 days. Vericel is unprofitable on a full-year basis (net income was negative) despite 20.2% annual revenue growth, and the company exhibits an elevated P/E of 4619.00 reflecting net losses. The combination of the outsized position reduction and the company's current profitability challenges creates a material signal worth investor attention.